Dynavax Technologies (DVAX) Financials

$9.80 -0.02 (-0.20%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$9.62 -0.18 (-1.88%)

As of 05/23/2025 07:21 PM Eastern

Annual Income Statements for Dynavax Technologies

This table shows Dynavax Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	27	-6.39	293	72	-75	-156	-159	-95	-112	-107	-91
Consolidated Net Income / (Loss)	27	-6.39	293	77	-75	-153	-159	-95	-112	-107	-91
Net Income / (Loss) Continuing Operations	27	-6.39	293	77	-75	-153	-159	-95	-112	-107	-91
Total Pre-Tax Income	31	-4.37	294	78	-75	-153	-159	-95	-110	-105	-91
Total Operating Income	-4.12	-37	284	134	-68	-135	-153	-96	-111	-105	-91
Total Gross Profit	228	182	461	266	35	25	-2.74	0.33	11	4.05	11
Total Revenue	277	232	723	439	47	35	8.20	0.33	11	4.05	11
Operating Revenue	277	232	723	439	47	35	8.20	0.33	11	4.05	11
Total Cost of Revenue	49	50	262	174	11	10	11	0.00	0.00	0.00	0.00
Operating Cost of Revenue	49	50	262	174	11	10	11	-	-	-	-
Total Operating Expenses	232	219	177	131	104	160	151	96	122	109	102
Selling, General & Admin Expense	170	153	131	100	79	75	65	27	37	22	17
Research & Development Expense	62	55	47	32	29	62	75	65	84	87	85
Other Operating Expenses / (Income)	0.00	12	0.00	0.00	-	-	-	-	-	-	-
Other Special Charges / (Income)	0.00	-1.00	-1.00	-1.00	-6.85	0.00	0.00	-	-	-	-
Total Other Income / (Expense), net	35	33	11	-57	-6.87	-18	-5.51	1.34	0.76	-0.37	0.16
Interest Expense	6.79	6.76	6.73	16	19	17	9.34	-	-	0.57	0.04
Interest & Investment Income	41	40	16	7.88	8.97	5.99	3.83	1.34	0.76	0.21	0.19
Other Income / (Expense), net	0.29	-0.15	1.80	-48	3.23	-6.77	0.00	-	-	-	-
Income Tax Expense	3.55	2.02	1.14	0.81	0.00	0.00	-	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	0.28	4.57	0.00	0.00	-	-	-	-	-
Basic Earnings per Share	$0.21	($0.05)	$2.32	$0.62	($0.75)	($2.16)	($2.55)	($1.81)	($2.92)	($3.25)	($3.45)
Weighted Average Basic Shares Outstanding	130.05M	128.73M	126.40M	116.26M	100.75M	72.02M	62.36M	52.61M	38.51M	32.88M	26.29M
Diluted Earnings per Share	$0.20	($0.05)	$1.97	$0.57	($0.78)	($2.16)	($2.55)	($1.81)	($2.92)	($3.25)	($3.45)
Weighted Average Diluted Shares Outstanding	133.34M	128.73M	150.80M	133.01M	101.50M	72.02M	62.36M	52.61M	38.51M	32.88M	26.29M
Weighted Average Basic & Diluted Shares Outstanding	124.07M	130.61M	127.69M	124.92M	113.26M	72.02M	62.36M	52.61M	38.51M	32.88M	26.29M

This table shows Dynavax Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-96	7.05	18	11	-8.72	0.22	14	3.43	-24	67	64
Consolidated Net Income / (Loss)	-96	7.05	18	11	-8.72	0.22	14	3.43	-24	68	64
Net Income / (Loss) Continuing Operations	-96	7.20	17	11	-8.72	0.22	14	3.43	-24	68	64
Total Pre-Tax Income	-98	7.63	20	15	-11	1.00	14	4.21	-24	68	64
Total Operating Income	-24	-1.63	10	5.20	-18	-8.49	5.12	-3.41	-30	63	61
Total Gross Profit	54	59	68	62	40	47	56	47	32	107	106
Total Revenue	68	72	81	74	51	56	70	60	47	184	168
Operating Revenue	68	72	81	74	51	56	70	60	47	184	168
Total Cost of Revenue	14	13	13	12	11	8.69	13	14	15	77	61
Operating Cost of Revenue	14	13	13	12	11	8.69	13	14	15	77	61
Total Operating Expenses	78	60	57	57	58	55	51	50	62	44	45
Selling, General & Admin Expense	48	42	43	42	44	41	38	37	37	31	32
Research & Development Expense	19	19	14	15	14	14	14	13	14	13	13
Other Operating Expenses / (Income)	11	-	0.00	0.00	0.00	-	0.00	0.00	12	-	0.00
Total Other Income / (Expense), net	-74	9.11	9.89	9.71	6.27	9.49	9.03	7.61	6.53	4.56	2.90
Interest Expense	84	1.70	1.70	1.70	1.70	1.69	1.69	1.69	1.69	1.68	1.69
Interest & Investment Income	7.74	13	9.38	9.20	9.47	17	8.46	7.38	6.60	6.35	4.59
Other Income / (Expense), net	1.80	-2.62	2.21	2.21	-1.50	-5.95	2.26	1.92	1.62	-0.11	0.00
Income Tax Expense	-1.78	0.58	2.22	3.52	-2.78	0.78	-0.15	0.78	0.62	0.24	0.28
Basic Earnings per Share	($0.77)	$0.06	$0.13	$0.09	($0.07)	-	$0.11	$0.03	($0.19)	$0.54	$0.50
Weighted Average Basic Shares Outstanding	124.87M	130.05M	131.13M	130.92M	130.20M	128.73M	128.99M	128.63M	127.92M	126.40M	127.06M
Diluted Earnings per Share	($0.77)	$0.07	$0.12	$0.08	($0.07)	$0.01	$0.10	$0.03	($0.19)	$0.45	$0.43
Weighted Average Diluted Shares Outstanding	124.87M	133.34M	154.81M	154.47M	130.20M	128.73M	154.20M	152.14M	127.92M	150.80M	151.54M
Weighted Average Basic & Diluted Shares Outstanding	120.08M	124.07M	131.45M	131.04M	130.89M	130.61M	129.26M	128.80M	128.49M	127.69M	127.58M

This table details how cash moves in and out of Dynavax Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-54	-52	-234	404	-7.79	39	23	2.32	-21	-4.70	26
Net Cash From Operating Activities	67	101	63	336	-92	-121	-131	-78	-107	-93	-74
Net Cash From Continuing Operating Activities	67	101	63	336	-92	-87	-131	-78	-107	-93	-74
Net Income / (Loss) Continuing Operations	27	-6.39	293	77	-75	-153	-159	-95	-112	-107	-91
Consolidated Net Income / (Loss)	27	-6.39	293	77	-75	-153	-159	-95	-112	-107	-91
Depreciation Expense	4.63	4.34	3.81	4.30	4.27	8.94	3.62	3.24	2.26	1.37	1.40
Amortization Expense	-11	-14	-1.33	3.23	5.60	11	9.30	1.00	0.18	0.66	0.88
Non-Cash Adjustments To Reconcile Net Income	57	51	201	74	-23	33	26	15	16	11	6.73
Changes in Operating Assets and Liabilities, net	-12	65	-434	177	-3.49	13	-12	-1.31	-13	1.12	7.97
Net Cash From Investing Activities	-18	-154	-316	14	-27	-43	55	-109	86	-86	91
Net Cash From Continuing Investing Activities	-18	-154	-316	14	-27	-29	55	-109	86	-86	91
Purchase of Property, Plant & Equipment	-6.35	-4.10	-7.14	-9.48	-4.07	-22	-4.19	-0.67	-7.76	-6.97	-1.67
Purchase of Investments	-524	-637	-632	-165	-202	-215	-214	-228	-127	-209	-45
Sale of Property, Plant & Equipment	0.00	1.00	1.00	1.00	6.85	0.00	0.00	-	-	-	-
Sale and/or Maturity of Investments	512	486	322	188	179	202	284	120	221	130	137
Net Cash From Financing Activities	-102	1.39	20	56	109	154	99	188	0.53	174	9.90
Net Cash From Continuing Financing Activities	-102	1.39	20	56	109	154	99	188	0.53	174	9.90
Repurchase of Common Equity	-100	0.00	0.00	-	-	-	-	-	-	-	-
Issuance of Common Equity	1.76	1.54	9.89	47	109	67	0.59	186	0.62	184	0.29
Other Financing Activities, net	-3.78	-0.15	9.64	-21	0.29	0.00	-0.52	1.61	-0.08	0.53	0.05
Other Net Changes in Cash	-0.86	0.32	-	-1.43	-	-	-	0.70	-0.26	-	-
Cash Interest Paid	5.64	5.64	5.64	9.82	17	12	6.58	-	-	0.72	-
Cash Income Taxes Paid	4.59	2.01	2.21	1.31	0.00	0.00	-	-	-	-	-

This table details how cash moves in and out of Dynavax Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-44	-23	6.84	-20	-18	-4.22	-72	52	-28	3.45	-51
Net Cash From Operating Activities	-20	53	19	11	-17	14	31	28	28	35	62
Net Cash From Continuing Operating Activities	-20	53	19	11	-17	14	31	28	28	35	62
Net Income / (Loss) Continuing Operations	-96	7.05	18	11	-8.72	0.22	14	3.43	-24	68	64
Consolidated Net Income / (Loss)	-96	7.05	18	11	-8.72	0.22	14	3.43	-24	68	64
Depreciation Expense	1.17	1.18	1.18	1.14	1.12	1.11	1.12	1.10	1.01	0.84	0.89
Amortization Expense	-1.27	-1.77	-2.56	-3.09	-3.70	-4.40	-3.30	-3.07	-2.86	-1.60	0.77
Non-Cash Adjustments To Reconcile Net Income	112	20	6.78	11	20	9.19	10	8.55	23	39	65
Changes in Operating Assets and Liabilities, net	-36	27	-3.53	-10	-25	7.64	8.60	18	31	-71	-68
Net Cash From Investing Activities	6.91	23	-15	-29	2.83	-20	-106	25	-52	-33	-119
Net Cash From Continuing Investing Activities	6.91	23	-15	-29	2.83	-20	-106	25	-52	-33	-119
Purchase of Property, Plant & Equipment	-3.93	-3.48	-1.35	-0.78	-0.75	-1.72	-0.35	-0.75	-1.28	-1.59	-1.28
Purchase of Investments	-94	-33	-165	-175	-151	-153	-225	-74	-185	-118	-201
Sale and/or Maturity of Investments	105	60	151	147	154	134	118	100	134	86	83
Net Cash From Financing Activities	-32	-99	2.48	-1.42	-4.20	1.78	2.99	-0.29	-3.09	0.15	8.06
Net Cash From Continuing Financing Activities	-32	-99	2.48	-1.42	-4.20	1.78	2.99	-0.29	-3.09	0.15	8.06
Repayment of Debt	-85	-	-	-	0.00	-	-	-	0.00	-	-
Repurchase of Common Equity	-29	-	-	-	-	-	-	-	-	-	-
Issuance of Debt	40	-	-	-	0.00	-	-	-	0.00	-	-
Issuance of Common Equity	0.84	-	0.86	-	0.90	-	0.76	-	0.78	0.00	0.72
Other Financing Activities, net	42	1.13	1.62	-1.42	-5.11	1.78	2.24	-0.29	-3.87	0.15	7.34
Effect of Exchange Rate Changes	0.46	-	0.36	-0.06	-0.20	-	-0.31	-	-	1.31	-
Cash Interest Paid	1.52	2.82	-	2.82	0.00	2.82	-	2.82	0.00	2.82	-
Cash Income Taxes Paid	0.41	0.01	1.61	2.01	0.95	0.60	0.70	0.68	0.03	1.42	0.28

This table presents Dynavax Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	986	997	986	1,039	353	279	211	219	110	217	138
Total Current Assets	849	859	917	973	290	209	174	198	90	200	127
Cash & Equivalents	96	150	202	436	32	40	49	27	24	45	50
Short-Term Investments	618	592	422	110	133	111	96	165	57	151	73
Accounts Receivable	47	45	148	132	23	8.89	3.70	0.85	1.34	1.39	0.73
Inventories, net	70	53	59	61	64	41	19	0.31	-	-	-
Prepaid Expenses	18	19	86	233	39	7.38	6.10	3.70	6.84	2.43	4.06
Plant, Property, & Equipment, net	39	37	38	35	31	32	17	17	17	14	7.92
Total Noncurrent Assets	98	101	31	32	33	38	19	4.14	2.91	2.88	2.93
Goodwill	1.95	2.07	2.01	2.13	2.30	2.08	2.14	2.24	1.97	2.04	2.28
Other Noncurrent Operating Assets	96	99	29	29	30	34	4.98	1.27	0.33	0.23	0.02
Total Liabilities & Shareholders' Equity	986	997	986	1,039	353	279	211	219	110	217	138
Total Liabilities	389	375	405	817	295	271	148	19	20	30	38
Total Current Liabilities	79	62	150	556	77	53	38	19	20	29	20
Accounts Payable	9.06	5.25	3.21	2.60	3.31	9.28	5.28	4.54	3.80	3.43	1.16
Accrued Expenses	65	52	35	54	22	19	26	14	16	23	13
Other Current Liabilities	4.20	4.52	111	149	14	25	7.00	-	-	-	-
Total Noncurrent Liabilities	311	313	255	260	217	218	110	0.64	0.44	0.77	18
Long-Term Debt	224	223	222	220	180	179	101	-	-	-	9.56
Other Noncurrent Operating Liabilities	87	90	33	40	37	39	8.92	0.64	0.44	0.77	1.07
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	597	622	581	222	59	8.29	63	200	89	187	100
Total Preferred & Common Equity	597	622	581	222	59	8.29	63	200	89	187	100
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Total Common Equity	597	622	581	222	59	8.29	63	200	89	187	100
Common Stock	1,505	1,555	1,511	1,442	1,352	1,230	1,131	1,108	905	890	695
Retained Earnings	-903	-931	-924	-1,217	-1,294	-1,219	-1,066	-907	-812	-700	-593
Accumulated Other Comprehensive Income / (Loss)	-4.72	-2.11	-5.44	-2.27	0.27	-2.39	-2.02	-0.88	-3.62	-2.93	-1.67

This table presents Dynavax Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	946	1,062	1,016	987	973	936	970	999
Total Current Assets	816	926	882	851	836	797	830	933
Cash & Equivalents	52	119	113	132	155	227	174	199
Short-Term Investments	610	645	623	592	566	455	478	388
Accounts Receivable	57	75	63	46	47	45	105	131
Inventories, net	74	62	62	62	49	53	58	103
Prepaid Expenses	24	25	21	20	19	17	16	113
Plant, Property, & Equipment, net	43	37	36	36	36	37	38	35
Total Noncurrent Assets	87	98	98	99	101	102	102	31
Goodwill	2.03	2.09	2.01	2.02	1.98	2.04	2.04	1.84
Other Noncurrent Operating Assets	85	96	96	97	99	99	99	29
Total Liabilities & Shareholders' Equity	946	1,062	1,016	987	973	936	970	999
Total Liabilities	415	381	373	368	368	359	406	499
Total Current Liabilities	68	70	62	56	54	45	92	244
Accounts Payable	4.33	7.09	4.56	2.43	3.12	3.25	7.30	3.05
Accrued Expenses	60	59	53	49	47	37	33	43
Other Current Liabilities	4.10	4.44	4.57	4.59	4.39	4.15	51	111
Total Noncurrent Liabilities	347	311	311	312	314	314	315	255
Long-Term Debt	261	224	223	223	222	222	222	221
Other Noncurrent Operating Liabilities	86	87	88	89	91	92	93	33
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	531	681	643	618	605	577	564	501
Total Preferred & Common Equity	531	681	643	618	605	577	564	501
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Total Common Equity	531	681	643	618	605	577	564	501
Common Stock	1,533	1,591	1,576	1,562	1,542	1,528	1,516	1,502
Retained Earnings	-999	-910	-928	-939	-931	-945	-949	-992
Accumulated Other Comprehensive Income / (Loss)	-2.64	0.51	-4.91	-4.37	-5.96	-5.37	-4.20	-9.26

This table displays calculated financial ratios and metrics derived from Dynavax Technologies' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.36%	-67.86%	64.45%	844.00%	32.18%	329.60%	2,407.03%	-97.04%	172.67%	-63.29%	-1.95%
EBITDA Growth	77.78%	-116.14%	207.55%	269.31%	54.52%	13.43%	-53.00%	15.25%	-5.07%	-15.75%	-38.59%
EBIT Growth	89.70%	-113.03%	231.56%	232.10%	54.00%	7.64%	-59.70%	13.28%	-5.36%	-15.07%	-37.33%
NOPAT Growth	85.92%	-109.18%	112.21%	378.07%	49.30%	12.05%	-59.70%	13.28%	-5.36%	-15.07%	-37.33%
Net Income Growth	527.44%	-102.18%	282.15%	201.96%	50.69%	3.96%	-66.99%	15.38%	-5.29%	-17.72%	-35.97%
EPS Growth	500.00%	-102.54%	245.61%	173.08%	63.89%	15.29%	-40.88%	38.01%	10.15%	5.80%	9.92%
Operating Cash Flow Growth	-33.86%	60.35%	-81.31%	463.71%	23.92%	7.65%	-69.38%	27.59%	-15.66%	-25.52%	-25.68%
Free Cash Flow Firm Growth	-116.06%	5,314.81%	-99.70%	462.25%	23.84%	4.92%	-75.95%	28.89%	-22.29%	-41.75%	-1.24%
Invested Capital Growth	4.25%	-42.50%	272.50%	-241.07%	105.59%	100.33%	151.64%	-1.64%	174.41%	27.09%	-253.71%
Revenue Q/Q Growth	6.30%	-35.69%	-1.44%	66.50%	59.04%	-7.97%	182.59%	-95.70%	148.94%	-28.22%	-4.91%
EBITDA Q/Q Growth	55.55%	-238.53%	-12.82%	523.35%	23.46%	3.70%	-6.84%	-9.09%	6.92%	-4.56%	-11.86%
EBIT Q/Q Growth	72.70%	-192.27%	-11.69%	408.08%	22.32%	2.62%	-7.07%	-9.74%	6.44%	-4.51%	-11.50%
NOPAT Q/Q Growth	60.70%	-176.74%	-6.20%	354.03%	18.47%	7.27%	-7.07%	-9.74%	6.44%	-4.51%	-11.50%
Net Income Q/Q Growth	33.36%	-110.45%	-9.85%	299.08%	22.05%	2.06%	-8.57%	-6.35%	4.36%	-4.48%	-11.33%
EPS Q/Q Growth	42.86%	-112.82%	-14.35%	1,050.00%	40.91%	10.37%	-9.44%	-16.77%	4.26%	-16.07%	-0.88%
Operating Cash Flow Q/Q Growth	143.93%	-17.40%	-57.70%	68.36%	7.30%	8.05%	-13.76%	9.92%	-4.32%	-5.69%	-7.31%
Free Cash Flow Firm Q/Q Growth	81.55%	-19.75%	-97.66%	36.08%	4.11%	11.29%	-12.85%	10.86%	-3.59%	-10.37%	-3.81%
Invested Capital Q/Q Growth	-24.24%	-4.16%	31.80%	18.39%	2.24%	-13.56%	7.84%	-41.74%	479.30%	4.63%	-37.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	82.17%	78.40%	63.73%	60.50%	75.49%	71.12%	-33.37%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-3.72%	-20.00%	39.83%	21.30%	-118.74%	-345.11%	-1,712.55%	-28,061.16%	-980.46%	-2,544.40%	-806.98%
Operating Margin	-1.49%	-15.94%	39.23%	30.60%	-146.87%	-382.87%	-1,870.20%	-29,359.33%	-1,002.51%	-2,594.40%	-827.69%
EBIT Margin	-1.38%	-16.01%	39.48%	19.58%	-139.94%	-402.09%	-1,870.20%	-29,359.33%	-1,002.51%	-2,594.40%	-827.69%
Profit (Net Income) Margin	9.85%	-2.75%	40.57%	17.46%	-161.63%	-433.29%	-1,938.27%	-29,099.08%	-1,018.24%	-2,636.89%	-822.35%
Tax Burden Percent	88.51%	146.30%	99.61%	98.96%	100.00%	100.00%	100.04%	100.51%	102.27%	101.28%	99.53%
Interest Burden Percent	-805.82%	11.75%	103.15%	90.08%	115.50%	107.76%	103.59%	98.61%	99.32%	100.35%	99.83%
Effective Tax Rate	11.49%	0.00%	0.39%	1.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-3.49%	-18.47%	754.22%	0.00%	-87.94%	-353.51%	-863.87%	-943.21%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-9.62%	-22.70%	751.27%	0.00%	-218.73%	294.92%	-820.49%	-922.84%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	7.97%	17.41%	-681.24%	0.00%	-136.72%	-74.21%	742.86%	877.30%	0.00%	0.00%	0.00%
Return on Equity (ROE)	4.48%	-1.06%	72.98%	54.59%	-224.65%	-427.72%	-121.01%	-65.91%	-81.40%	-74.28%	-63.27%
Cash Return on Invested Capital (CROIC)	-7.64%	35.49%	0.52%	0.00%	-157.04%	-420.33%	-950.12%	-941.55%	-1,313.11%	0.00%	0.00%
Operating Return on Assets (OROA)	-0.39%	-3.75%	28.18%	12.36%	-20.60%	-57.81%	-71.37%	-58.46%	-67.85%	-59.21%	-53.26%
Return on Assets (ROA)	2.75%	-0.64%	28.95%	11.02%	-23.80%	-62.29%	-73.96%	-57.94%	-68.92%	-60.18%	-52.91%
Return on Common Equity (ROCE)	4.48%	-1.06%	72.98%	54.59%	-224.65%	-427.72%	-121.01%	-65.91%	-81.40%	-74.28%	-63.27%
Return on Equity Simple (ROE_SIMPLE)	4.58%	-1.03%	50.46%	34.50%	-128.19%	-1,840.77%	-251.96%	-47.68%	-126.06%	-57.09%	-90.29%
Net Operating Profit after Tax (NOPAT)	-3.65	-26	282	133	-48	-94	-107	-67	-77	-74	-64
NOPAT Margin	-1.32%	-11.16%	39.08%	30.28%	-102.81%	-268.01%	-1,309.14%	-20,551.53%	-701.76%	-1,816.08%	-579.38%
Net Nonoperating Expense Percent (NNEP)	6.13%	4.23%	2.95%	-36.24%	130.79%	-648.43%	-43.38%	-20.36%	-25.08%	-21.42%	-17.65%
Return On Investment Capital (ROIC_SIMPLE)	-0.44%	-3.07%	35.19%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	17.83%	21.60%	36.28%	39.50%	24.51%	28.88%	133.37%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	61.45%	65.84%	18.18%	22.79%	170.26%	212.91%	790.07%	8,369.11%	337.38%	547.65%	157.51%
R&D to Revenue	22.20%	23.63%	6.45%	7.33%	61.45%	176.98%	914.26%	19,874.01%	765.13%	2,146.74%	766.68%
Operating Expenses to Revenue	83.65%	94.34%	24.49%	29.90%	222.36%	453.99%	1,836.83%	29,459.33%	1,102.51%	2,694.40%	927.69%
Earnings before Interest and Taxes (EBIT)	-3.83	-37	285	86	-65	-142	-153	-96	-111	-105	-91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-10	-46	288	94	-55	-122	-140	-92	-108	-103	-89
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.81	2.90	2.34	7.59	8.35	57.87	9.10	5.68	1.71	4.96	4.41
Price to Tangible Book Value (P/TBV)	2.82	2.91	2.34	7.66	8.69	129.34	11.66	5.74	1.74	5.02	4.51
Price to Revenue (P/Rev)	6.05	7.78	1.88	3.84	10.53	13.62	69.97	3,465.29	13.78	229.22	40.18
Price to Earnings (P/E)	61.47	0.00	4.64	23.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.63%	0.00%	21.57%	4.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	11.13	12.56	5.36	0.00	6.90	14.24	29.75	133.21	9.85	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	4.29	5.54	1.32	3.10	10.85	14.40	64.52	2,878.58	6.41	180.80	29.93
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	3.32	14.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	3.35	15.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	3.38	10.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.87	12.80	15.22	4.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	25.85	1,037.87	4.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.38	0.36	0.38	0.99	3.06	21.54	1.60	0.00	0.00	0.00	0.10
Long-Term Debt to Equity	0.38	0.36	0.38	0.99	3.06	21.54	1.60	0.00	0.00	0.00	0.10
Financial Leverage	-0.83	-0.77	-0.91	-1.11	0.63	-0.25	-0.91	-0.95	-1.01	-1.08	-1.06
Leverage Ratio	1.63	1.65	2.52	4.95	9.44	6.87	1.64	1.14	1.18	1.23	1.20
Compound Leverage Factor	-13.11	0.19	2.60	4.46	10.90	7.40	1.69	1.12	1.17	1.24	1.19
Debt to Total Capital	27.28%	26.36%	27.61%	49.79%	75.39%	95.56%	61.53%	0.00%	0.00%	0.00%	8.69%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	27.28%	26.36%	27.61%	49.79%	75.39%	95.56%	61.53%	0.00%	0.00%	0.00%	8.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	72.72%	73.64%	72.39%	50.21%	24.61%	4.44%	38.47%	100.00%	100.00%	100.00%	91.31%
Debt to EBITDA	-21.69	-4.79	0.77	2.36	-3.25	-1.47	-0.72	0.00	0.00	0.00	-0.11
Net Debt to EBITDA	47.47	11.18	-1.40	-3.48	-0.27	-0.23	0.32	0.00	0.00	0.00	1.27
Long-Term Debt to EBITDA	-21.69	-4.79	0.77	2.36	-3.25	-1.47	-0.72	0.00	0.00	0.00	-0.11
Debt to NOPAT	-61.36	-8.59	0.78	1.66	-3.76	-1.89	-0.94	0.00	0.00	0.00	-0.15
Net Debt to NOPAT	134.30	20.05	-1.43	-2.45	-0.31	-0.29	0.42	0.00	0.00	0.00	1.77
Long-Term Debt to NOPAT	-61.36	-8.59	0.78	1.66	-3.76	-1.89	-0.94	0.00	0.00	0.00	-0.15
Altman Z-Score	2.51	2.65	3.32	0.78	-3.88	-5.93	-6.33	29.08	-8.38	13.69	-0.14
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	10.80	13.81	6.11	1.75	3.75	3.93	4.58	10.65	4.47	6.95	6.28
Quick Ratio	9.67	12.65	5.14	1.22	2.42	3.02	3.92	10.36	4.13	6.86	6.08
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-8.00	50	0.92	310	-85	-112	-118	-67	-94	-77	-54
Operating Cash Flow to CapEx	1,047.10%	3,239.79%	1,021.60%	3,958.10%	0.00%	-541.28%	-3,135.92%	-11,587.15%	-1,380.06%	-1,327.96%	-4,423.40%
Free Cash Flow to Firm to Interest Expense	-1.18	7.37	0.14	18.87	-4.48	-6.61	-12.64	0.00	0.00	-134.86	-1,554.82
Operating Cash Flow to Interest Expense	9.79	14.88	9.32	20.45	-4.84	-7.14	-14.06	0.00	0.00	-161.82	-2,106.80
Operating Cash Flow Less CapEx to Interest Expense	8.85	14.42	8.40	19.93	-4.69	-8.46	-14.51	0.00	0.00	-174.00	-2,154.43
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.28	0.23	0.71	0.63	0.15	0.14	0.04	0.00	0.07	0.02	0.06
Accounts Receivable Turnover	6.06	2.42	5.17	5.69	2.95	5.59	3.60	0.30	8.07	3.82	9.37
Inventory Turnover	0.80	0.89	4.34	2.78	0.22	0.34	1.13	0.00	0.00	0.00	0.00
Fixed Asset Turnover	7.27	6.20	19.90	13.40	1.49	1.44	0.49	0.02	0.71	0.37	1.33
Accounts Payable Turnover	6.91	11.87	90.23	58.72	1.81	1.40	2.23	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	60.19	150.89	70.54	64.15	123.68	65.24	101.47	1,225.60	45.22	95.58	38.94
Days Inventory Outstanding (DIO)	455.26	410.12	84.08	131.45	1,679.78	1,082.84	322.70	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	52.80	30.76	4.05	6.22	201.37	261.16	163.86	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	462.65	530.24	150.58	189.39	1,602.09	886.92	260.32	1,225.60	45.22	95.58	38.94
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	107	102	178	-103	73	36	18	7.07	7.18	-9.66	-13
Invested Capital Turnover	2.65	1.66	19.30	-29.22	0.86	1.32	0.66	0.05	-8.94	-0.35	-1.30
Increase / (Decrease) in Invested Capital	4.35	-76	282	-177	38	18	11	-0.12	17	3.59	-9.50
Enterprise Value (EV)	1,189	1,287	955	1,362	505	507	529	941	71	732	330
Market Capitalization	1,679	1,807	1,358	1,688	490	480	574	1,133	152	928	443
Book Value per Share	$4.54	$4.81	$4.55	$1.85	$0.53	$0.10	$1.01	$3.29	$2.32	$4.87	$0.38
Tangible Book Value per Share	$4.53	$4.80	$4.54	$1.84	$0.51	$0.04	$0.78	$3.26	$2.26	$4.82	$0.37
Total Capital	821	845	803	443	239	187	164	200	89	187	110
Total Debt	224	223	222	220	180	179	101	0.00	0.00	0.00	9.56
Total Long-Term Debt	224	223	222	220	180	179	101	0.00	0.00	0.00	9.56
Net Debt	-490	-520	-403	-325	15	28	-45	-192	-81	-196	-113
Capital Expenditures (CapEx)	6.35	3.10	6.14	8.48	-2.78	22	4.19	0.67	7.76	6.97	1.67
Debt-free, Cash-free Net Working Capital (DFCFNWC)	56	55	143	-130	48	4.55	-9.21	-12	-12	-25	-15
Debt-free Net Working Capital (DFNWC)	770	797	767	416	213	156	136	179	70	171	107
Net Working Capital (NWC)	770	797	767	416	213	156	136	179	70	171	107
Net Nonoperating Expense (NNE)	-31	-20	-11	56	27	58	52	28	35	33	27
Net Nonoperating Obligations (NNO)	-490	-520	-403	-326	15	27	-45	-192	-82	-197	-114
Total Depreciation and Amortization (D&A)	-6.49	-9.28	2.49	7.53	9.87	20	13	4.25	2.44	2.03	2.29
Debt-free, Cash-free Net Working Capital to Revenue	20.37%	23.52%	19.72%	-29.54%	102.18%	12.92%	-112.28%	-3,799.39%	-107.33%	-616.40%	-140.45%
Debt-free Net Working Capital to Revenue	277.84%	343.08%	106.12%	94.69%	456.71%	441.82%	1,662.98%	54,871.56%	629.93%	4,226.20%	971.34%
Net Working Capital to Revenue	277.84%	343.08%	106.12%	94.69%	456.71%	441.82%	1,662.98%	54,871.56%	629.93%	4,226.20%	971.34%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.21	($0.05)	$2.32	$0.62	($0.75)	($2.16)	($2.55)	($1.81)	($2.92)	($3.25)	($3.45)
Adjusted Weighted Average Basic Shares Outstanding	130.05M	128.73M	126.40M	116.26M	100.75M	86.19M	64.00M	61.68M	44.35M	38.48M	28.91M
Adjusted Diluted Earnings per Share	$0.20	($0.05)	$1.97	$0.57	($0.78)	($2.16)	($2.55)	($1.81)	($2.92)	($3.25)	($3.45)
Adjusted Weighted Average Diluted Shares Outstanding	133.34M	128.73M	150.80M	133.01M	101.50M	86.19M	64.00M	61.68M	44.35M	38.48M	28.91M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	($2.16)	($2.55)	($1.81)	($2.92)	($3.25)	($3.45)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	124.07M	130.61M	127.69M	124.92M	113.26M	72.02M	62.36M	52.61M	38.51M	32.88M	26.29M
Normalized Net Operating Profit after Tax (NOPAT)	-3.65	-27	281	132	-53	-85	-107	-65	-77	-74	-64
Normalized NOPAT Margin	-1.32%	-11.46%	38.94%	30.06%	-113.11%	-241.46%	-1,309.14%	-19,955.78%	-701.76%	-1,816.08%	-576.94%
Pre Tax Income Margin	11.13%	-1.88%	40.72%	17.64%	-161.63%	-433.29%	-1,937.41%	-28,950.46%	-995.67%	-2,603.46%	-826.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.56	-5.50	42.38	5.24	-3.42	-8.34	-16.42	0.00	0.00	-183.69	-2,608.89
NOPAT to Interest Expense	-0.54	-3.84	41.95	8.11	-2.51	-5.56	-11.49	0.00	0.00	-128.59	-1,826.22
EBIT Less CapEx to Interest Expense	-1.50	-5.96	41.47	4.73	-3.27	-9.66	-16.87	0.00	0.00	-195.88	-2,656.51
NOPAT Less CapEx to Interest Expense	-1.47	-4.30	41.04	7.59	-2.37	-6.88	-11.94	0.00	0.00	-140.77	-1,873.85
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	366.18%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Dynavax Technologies' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	34.21%	29.56%	15.99%	22.48%	8.24%	-69.87%	-58.56%	-76.51%	-58.83%	-5.42%	54.92%
EBITDA Growth	-0.36%	72.75%	110.09%	257.60%	28.29%	-128.47%	-91.76%	-102.69%	-189.05%	-40.47%	317.52%
EBIT Growth	-13.27%	70.59%	66.60%	599.19%	32.69%	-122.92%	-87.99%	-101.16%	-187.63%	-37.47%	313.07%
NOPAT Growth	-32.98%	19.16%	73.15%	242.98%	41.26%	-102.97%	-91.54%	-102.18%	-168.83%	-22.06%	443.46%
Net Income Growth	-1,001.93%	3,119.18%	23.10%	231.86%	64.16%	-99.68%	-77.60%	-97.34%	-174.05%	-32.12%	324.44%
EPS Growth	-1,000.00%	600.00%	20.00%	166.67%	63.16%	-97.78%	-76.74%	-96.55%	-186.36%	-42.31%	279.17%
Operating Cash Flow Growth	-17.75%	285.09%	-37.46%	-61.80%	-160.38%	-60.61%	-49.43%	68.43%	154.76%	-71.00%	-7.02%
Free Cash Flow Firm Growth	-1,039.80%	-107.93%	-175.11%	-275.98%	102.04%	133.79%	116.67%	112.52%	-306.02%	-184.97%	-195.80%
Invested Capital Growth	10.33%	4.25%	31.88%	10.97%	-11.61%	-42.50%	-20.92%	-6.26%	2,672.10%	272.50%	206.81%
Revenue Q/Q Growth	-5.37%	-10.66%	9.26%	45.29%	-8.64%	-20.02%	15.38%	28.39%	-74.57%	9.99%	-34.60%
EBITDA Q/Q Growth	-353.90%	-144.26%	100.44%	124.92%	-38.85%	-441.27%	250.36%	88.66%	-148.93%	-1.26%	-50.84%
EBIT Q/Q Growth	-413.70%	-134.58%	65.97%	138.42%	-54.75%	-295.86%	597.30%	94.82%	-145.42%	2.66%	-52.12%
NOPAT Q/Q Growth	-995.97%	-116.86%	125.43%	131.92%	-566.22%	-136.12%	286.15%	86.88%	-133.66%	2.92%	-52.10%
Net Income Q/Q Growth	-1,463.11%	-59.93%	54.52%	230.56%	-4,082.19%	-98.47%	316.58%	114.10%	-135.92%	6.15%	-50.44%
EPS Q/Q Growth	-1,200.00%	-41.67%	50.00%	214.29%	-800.00%	-90.00%	233.33%	115.79%	-142.22%	4.65%	-50.57%
Operating Cash Flow Q/Q Growth	-137.05%	172.31%	81.71%	164.23%	-221.16%	-55.78%	10.99%	1.54%	-20.96%	-43.23%	269.71%
Free Cash Flow Firm Q/Q Growth	-390.20%	76.68%	-181.27%	-392.29%	-95.86%	120.76%	559.01%	103.39%	31.48%	-8.94%	-394.98%
Invested Capital Q/Q Growth	21.81%	-24.24%	8.04%	10.67%	15.09%	-4.16%	-9.09%	-11.86%	-25.13%	31.80%	7.77%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	79.80%	81.38%	83.77%	83.76%	78.41%	84.37%	80.97%	77.53%	68.65%	58.00%	63.43%
EBITDA Margin	-32.17%	-6.71%	13.54%	7.38%	-43.02%	-31.89%	7.47%	-5.73%	-64.93%	33.75%	37.60%
Operating Margin	-34.67%	-2.27%	12.50%	7.04%	-34.99%	-15.27%	7.36%	-5.65%	-64.46%	34.22%	36.60%
EBIT Margin	-32.02%	-5.90%	15.24%	10.03%	-37.94%	-25.98%	10.61%	-2.46%	-61.01%	34.16%	36.60%
Profit (Net Income) Margin	-140.98%	9.79%	21.82%	15.43%	-17.17%	0.39%	20.56%	5.69%	-51.85%	36.71%	38.04%
Tax Burden Percent	98.19%	92.42%	88.78%	76.39%	75.85%	21.99%	101.04%	81.55%	102.60%	99.65%	99.56%
Interest Burden Percent	448.41%	-179.52%	161.29%	201.35%	59.66%	-6.90%	191.81%	-283.68%	82.84%	107.84%	104.39%
Effective Tax Rate	0.00%	7.58%	11.22%	23.61%	0.00%	78.01%	-1.04%	18.45%	0.00%	0.35%	0.44%
Return on Invested Capital (ROIC)	-57.65%	-5.55%	23.36%	10.83%	-46.02%	-5.56%	22.19%	-17.42%	-428.01%	658.11%	6,197.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-40.00%	-7.25%	21.69%	9.30%	-46.82%	-6.01%	20.07%	-19.06%	-427.13%	656.79%	6,196.04%
Return on Net Nonoperating Assets (RNNOA)	31.36%	6.00%	-17.51%	-7.41%	36.86%	4.61%	-15.68%	14.43%	357.76%	-595.56%	-6,101.99%
Return on Equity (ROE)	-26.28%	0.45%	5.85%	3.42%	-9.15%	-0.95%	6.51%	-2.99%	-70.25%	62.55%	95.01%
Cash Return on Invested Capital (CROIC)	-15.46%	-7.64%	-34.98%	-22.30%	-10.61%	35.49%	51.27%	79.97%	133.48%	0.52%	29.08%
Operating Return on Assets (OROA)	-9.76%	-1.65%	3.91%	2.57%	-9.16%	-6.09%	3.89%	-1.15%	-40.42%	24.38%	27.97%
Return on Assets (ROA)	-42.99%	2.74%	5.59%	3.95%	-4.15%	0.09%	7.53%	2.67%	-34.36%	26.20%	29.07%
Return on Common Equity (ROCE)	-26.28%	0.45%	5.85%	3.42%	-9.15%	-0.95%	6.51%	-2.99%	-70.25%	62.55%	95.01%
Return on Equity Simple (ROE_SIMPLE)	-11.31%	0.00%	3.01%	2.67%	1.49%	0.00%	10.10%	19.17%	41.86%	0.00%	64.97%
Net Operating Profit after Tax (NOPAT)	-17	-1.51	8.95	3.97	-12	-1.87	5.17	-2.78	-21	63	61
NOPAT Margin	-24.27%	-2.10%	11.10%	5.38%	-24.49%	-3.36%	7.44%	-4.61%	-45.12%	34.10%	36.44%
Net Nonoperating Expense Percent (NNEP)	-17.65%	1.70%	1.66%	1.53%	0.80%	0.45%	2.11%	1.64%	-0.89%	1.32%	0.96%
Return On Investment Capital (ROIC_SIMPLE)	-2.09%	-0.18%	-	-	-	-0.22%	-	-	-	7.84%	-
Cost of Revenue to Revenue	20.20%	18.62%	16.23%	16.24%	21.59%	15.63%	19.03%	22.47%	31.35%	42.00%	36.57%
SG&A Expenses to Revenue	69.95%	57.73%	53.41%	56.46%	86.76%	74.25%	54.74%	61.53%	77.88%	16.81%	19.10%
R&D to Revenue	28.43%	25.92%	17.86%	20.26%	26.64%	25.40%	20.31%	21.65%	28.99%	6.97%	7.73%
Operating Expenses to Revenue	114.47%	83.65%	71.27%	76.72%	113.39%	99.64%	73.61%	83.18%	133.11%	23.78%	26.83%
Earnings before Interest and Taxes (EBIT)	-22	-4.25	12	7.40	-19	-14	7.38	-1.48	-29	63	61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-22	-4.83	11	5.45	-22	-18	5.20	-3.46	-30	62	63
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.03	2.81	2.14	2.29	2.59	2.90	3.14	2.88	2.22	2.34	2.64
Price to Tangible Book Value (P/TBV)	3.04	2.82	2.15	2.29	2.60	2.91	3.16	2.89	2.23	2.34	2.65
Price to Revenue (P/Rev)	5.46	6.05	5.60	5.89	6.79	7.78	5.27	3.61	1.91	1.88	1.80
Price to Earnings (P/E)	0.00	61.47	71.29	85.57	173.95	0.00	31.27	15.04	5.31	4.64	4.12
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	1.63%	1.40%	1.17%	0.57%	0.00%	3.20%	6.65%	18.82%	21.57%	24.28%
Enterprise Value to Invested Capital (EV/IC)	9.29	11.13	6.52	7.34	9.36	12.56	13.14	10.21	6.16	5.36	7.06
Enterprise Value to Revenue (EV/Rev)	4.10	4.29	3.53	3.84	4.67	5.54	3.89	2.61	1.25	1.32	1.30
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	41.87	13.14	3.69	3.32	2.89
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	34.85	12.73	3.67	3.35	2.96
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	41.58	13.44	3.72	3.38	3.17
Enterprise Value to Operating Cash Flow (EV/OCF)	19.01	17.87	33.72	24.60	19.61	12.80	11.54	7.89	5.84	15.22	6.44
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	25.85	22.63	12.35	8.92	1,037.87	24.29
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.49	0.38	0.33	0.35	0.36	0.36	0.37	0.38	0.39	0.38	0.44
Long-Term Debt to Equity	0.49	0.38	0.33	0.35	0.36	0.36	0.37	0.38	0.39	0.38	0.44
Financial Leverage	-0.78	-0.83	-0.81	-0.80	-0.79	-0.77	-0.78	-0.76	-0.84	-0.91	-0.98
Leverage Ratio	1.68	1.63	1.58	1.60	1.65	1.65	1.78	1.96	2.32	2.52	3.38
Compound Leverage Factor	7.54	-2.92	2.55	3.22	0.99	-0.11	3.42	-5.56	1.93	2.72	3.53
Debt to Total Capital	32.92%	27.28%	24.70%	25.78%	26.50%	26.36%	26.88%	27.79%	28.24%	27.61%	30.66%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	32.92%	27.28%	24.70%	25.78%	26.50%	26.36%	26.88%	27.79%	28.24%	27.61%	30.66%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	67.08%	72.72%	75.30%	74.22%	73.50%	73.64%	73.12%	72.21%	71.76%	72.39%	69.34%
Debt to EBITDA	-25.05	-21.69	-9.63	-7.72	-5.89	-4.79	6.63	2.43	0.99	0.77	0.67
Net Debt to EBITDA	38.54	47.47	23.27	17.70	13.23	11.18	-14.85	-5.03	-1.93	-1.40	-1.11
Long-Term Debt to EBITDA	-25.05	-21.69	-9.63	-7.72	-5.89	-4.79	6.63	2.43	0.99	0.77	0.67
Debt to NOPAT	-37.28	-61.36	-24.08	-15.12	-7.73	-8.59	6.58	2.49	1.00	0.78	0.74
Net Debt to NOPAT	57.36	134.30	58.22	34.70	17.36	20.05	-14.74	-5.14	-1.95	-1.43	-1.21
Long-Term Debt to NOPAT	-37.28	-61.36	-24.08	-15.12	-7.73	-8.59	6.58	2.49	1.00	0.78	0.74
Altman Z-Score	2.03	2.51	2.35	2.32	2.42	2.73	3.12	2.81	1.97	2.58	1.96
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	11.93	10.80	13.23	14.18	15.20	13.81	15.40	17.78	9.07	6.11	3.82
Quick Ratio	10.50	9.67	11.98	12.84	13.74	12.65	14.14	16.20	8.27	5.14	2.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-29	-5.86	-25	-8.93	3.06	74	33	5.08	-150	-219	-201
Operating Cash Flow to CapEx	-499.97%	1,524.18%	1,446.29%	1,375.22%	-2,226.84%	798.96%	8,970.89%	3,734.49%	2,152.92%	2,202.14%	4,805.62%
Free Cash Flow to Firm to Interest Expense	-0.34	-3.44	-14.79	-5.26	1.80	43.65	19.79	3.01	-88.84	-129.80	-119.08
Operating Cash Flow to Interest Expense	-0.23	31.15	11.46	6.31	-9.84	8.14	18.41	16.61	16.38	20.75	36.53
Operating Cash Flow Less CapEx to Interest Expense	-0.28	29.10	10.67	5.85	-10.28	7.12	18.20	16.17	15.62	19.81	35.77
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.30	0.28	0.26	0.26	0.24	0.23	0.37	0.47	0.66	0.71	0.76
Accounts Receivable Turnover	5.74	6.06	4.27	4.62	3.13	2.42	4.06	4.18	5.42	5.17	4.42
Inventory Turnover	0.77	0.80	0.80	0.78	0.78	0.89	1.57	2.63	3.47	4.34	3.04
Fixed Asset Turnover	7.39	7.27	7.09	6.79	6.33	6.20	10.10	12.46	17.58	19.90	21.07
Accounts Payable Turnover	15.46	6.91	8.76	11.50	9.54	11.87	38.56	40.72	17.24	90.23	77.84
Days Sales Outstanding (DSO)	63.62	60.19	85.47	78.92	116.71	150.89	89.93	87.24	67.31	70.54	82.50
Days Inventory Outstanding (DIO)	475.77	455.26	456.27	469.99	469.80	410.12	233.21	138.80	105.33	84.08	119.87
Days Payable Outstanding (DPO)	23.62	52.80	41.66	31.73	38.24	30.76	9.47	8.96	21.18	4.05	4.69
Cash Conversion Cycle (CCC)	515.78	462.65	500.08	517.18	548.27	530.24	313.68	217.07	151.46	150.58	197.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	130	107	141	131	118	102	107	118	133	178	135
Invested Capital Turnover	2.38	2.65	2.10	2.01	1.88	1.66	2.98	3.78	9.49	19.30	170.05
Increase / (Decrease) in Invested Capital	12	4.35	34	13	-15	-76	-28	-7.85	129	282	262
Enterprise Value (EV)	1,208	1,189	919	958	1,104	1,287	1,404	1,201	823	955	955
Market Capitalization	1,609	1,679	1,460	1,470	1,604	1,807	1,902	1,660	1,253	1,358	1,320
Book Value per Share	$4.28	$4.54	$5.20	$4.91	$4.75	$4.81	$4.70	$4.49	$4.42	$4.55	$3.96
Tangible Book Value per Share	$4.26	$4.53	$5.18	$4.90	$4.73	$4.80	$4.68	$4.48	$4.40	$4.54	$3.94
Total Capital	791	821	905	866	841	845	827	799	786	803	722
Total Debt	261	224	224	223	223	223	222	222	222	222	221
Total Long-Term Debt	261	224	224	223	223	223	222	222	222	222	221
Net Debt	-401	-490	-540	-512	-501	-520	-498	-459	-430	-403	-365
Capital Expenditures (CapEx)	3.93	3.48	1.35	0.78	0.75	1.72	0.35	0.75	1.28	1.59	1.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	86	56	92	84	72	55	61	71	87	143	102
Debt-free Net Working Capital (DFNWC)	748	770	856	820	795	797	781	753	739	767	689
Net Working Capital (NWC)	748	770	856	820	795	797	781	753	739	767	689
Net Nonoperating Expense (NNE)	80	-8.56	-8.64	-7.42	-3.72	-2.09	-9.12	-6.21	3.16	-4.82	-2.68
Net Nonoperating Obligations (NNO)	-401	-490	-540	-512	-501	-520	-498	-460	-430	-403	-365
Total Depreciation and Amortization (D&A)	-0.10	-0.58	-1.37	-1.96	-2.58	-3.28	-2.18	-1.97	-1.84	-0.76	1.66
Debt-free, Cash-free Net Working Capital to Revenue	29.28%	20.37%	35.36%	33.72%	30.38%	23.52%	16.89%	15.47%	13.22%	19.72%	13.96%
Debt-free Net Working Capital to Revenue	253.75%	277.84%	328.29%	328.33%	336.77%	343.08%	216.35%	163.82%	112.66%	106.12%	93.95%
Net Working Capital to Revenue	253.75%	277.84%	328.29%	328.33%	336.77%	343.08%	216.35%	163.82%	112.66%	106.12%	93.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.77)	$0.06	$0.13	$0.09	($0.07)	$0.00	$0.11	$0.03	($0.19)	$0.54	$0.50
Adjusted Weighted Average Basic Shares Outstanding	124.87M	130.05M	131.13M	130.92M	130.20M	128.73M	128.99M	128.63M	127.92M	126.40M	127.06M
Adjusted Diluted Earnings per Share	($0.77)	$0.07	$0.12	$0.08	($0.07)	$0.01	$0.10	$0.03	($0.19)	$0.45	$0.43
Adjusted Weighted Average Diluted Shares Outstanding	124.87M	133.34M	154.81M	154.47M	130.20M	128.73M	154.20M	152.14M	127.92M	150.80M	151.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	120.08M	124.07M	131.45M	131.04M	130.89M	130.61M	129.26M	128.80M	128.49M	127.69M	127.58M
Normalized Net Operating Profit after Tax (NOPAT)	-17	-1.51	8.95	3.97	-12	-5.94	2.88	-2.78	-21	63	61
Normalized NOPAT Margin	-24.27%	-2.10%	11.10%	5.38%	-24.49%	-10.69%	4.14%	-4.61%	-45.12%	34.10%	36.44%
Pre Tax Income Margin	-143.59%	10.59%	24.58%	20.20%	-22.64%	1.79%	20.35%	6.98%	-50.54%	36.84%	38.21%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.26	-2.50	7.23	4.36	-11.37	-8.54	4.36	-0.88	-16.98	37.43	36.44
NOPAT to Interest Expense	-0.20	-0.89	5.27	2.34	-7.34	-1.10	3.06	-1.65	-12.56	37.36	36.28
EBIT Less CapEx to Interest Expense	-0.31	-4.54	6.44	3.90	-11.81	-9.56	4.16	-1.32	-17.74	36.49	35.68
NOPAT Less CapEx to Interest Expense	-0.24	-2.93	4.48	1.88	-7.78	-2.12	2.85	-2.09	-13.32	36.42	35.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-215.53%	366.18%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Dynavax Technologies' Financials

When does Dynavax Technologies's fiscal year end?

According to the most recent income statement we have on file, Dynavax Technologies' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Dynavax Technologies' net income changed over the last 10 years?

Dynavax Technologies' net income appears to be on a downward trend, with a most recent value of $27.31 million in 2024, falling from -$90.72 million in 2014. The previous period was -$6.39 million in 2023. View Dynavax Technologies' forecast to see where analysts expect Dynavax Technologies to go next.

What is Dynavax Technologies's operating income?

Dynavax Technologies's total operating income in 2024 was -$4.12 million, based on the following breakdown:

Total Gross Profit: $227.80 million
Total Operating Expenses: $231.92 million

How has Dynavax Technologies revenue changed over the last 10 years?

Over the last 10 years, Dynavax Technologies' total revenue changed from $11.03 million in 2014 to $277.25 million in 2024, a change of 2,413.1%.

How much debt does Dynavax Technologies have?

Dynavax Technologies' total liabilities were at $389.46 million at the end of 2024, a 3.8% increase from 2023, and a 930.1% increase since 2014.

How much cash does Dynavax Technologies have?

In the past 10 years, Dynavax Technologies' cash and equivalents has ranged from $24.29 million in 2016 to $436.19 million in 2021, and is currently $95.88 million as of their latest financial filing in 2024.

How has Dynavax Technologies' book value per share changed over the last 10 years?

Over the last 10 years, Dynavax Technologies' book value per share changed from 0.38 in 2014 to 4.54 in 2024, a change of 1,087.9%.

Related Companies

This page (NASDAQ:DVAX) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dynavax Technologies (DVAX) Financials

Frequently Asked Questions About Dynavax Technologies' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dynavax Technologies (DVAX) Financials

Annual Income Statements for Dynavax Technologies

Quarterly Income Statements for Dynavax Technologies

Annual Cash Flow Statements for Dynavax Technologies

Quarterly Cash Flow Statements for Dynavax Technologies

Annual Balance Sheets for Dynavax Technologies

Quarterly Balance Sheets for Dynavax Technologies

Annual Metrics And Ratios for Dynavax Technologies

Quarterly Metrics And Ratios for Dynavax Technologies

Frequently Asked Questions About Dynavax Technologies' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools